Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-21-034364
Filing Date
2021-10-12
Accepted
2021-10-12 16:30:17
Documents
1
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 5337
  Complete submission text file 0001140361-21-034364.txt   6784
Mailing Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Issuer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address
Trochimiuk Janetta (Reporting) CIK: 0001807629 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37568 | Film No.: 211318878